We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pfizer Inc | NYSE:PFE | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.61 | 2.24% | 27.79 | 27.94 | 27.12 | 27.21 | 70,072,106 | 01:00:00 |
From May 2021 to May 2024
By Matt Grossman
Pfizer Inc. and BioNTech SE will expand a program to provide doses of their Comirnaty Covid-19 vaccine to poor countries at a not-for-profit price, the companies said Wednesday.
Under the program, the two companies provide doses of their vaccine to the U.S. government, which pays them a not-for-profit price and then donates the doses to low- and lower-middle-income countries and support organizations.
Pfizer and BioNTech will expand the program by 500 million doses, bringing its total size to one billion doses.
The companies are planning to produce the doses for the program at Pfizer facilities in Kalamazoo, Mich.; Andover, Mass.; Chesterfield, Mo. and McPherson, Kan. Delivery of the first 500 million doses began in August, and all one billion are expected to be delivered by September 2022.
World-wide, the two companies have now shipped more than 1.5 billion COvid-19 vaccine doses in all, they said.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
September 22, 2021 06:31 ET (10:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
